Le Lézard
Classified in: Health, Science and technology
Subjects: PDT, TDS, FVT

Ziosoft to Feature New Ziostation REVORAS Platform at the Annual American Association of Thoracic Surgeons Conference


Pioneer in 3D/4D Visualization to Showcase Next Generation Thoracic Surgery Planning Software for Complex Segmentectomy Procedures

NEWARK, Calif., April 25, 2024 /PRNewswire-PRWeb/ -- Ziosoft, a pioneer in 3D/4D AI medical visualization, will feature its unique REVORAS-enabled thoracic surgical planning capabilities at the annual American Association of Thoracic Surgeons (AATS) conference being held April 27 - 29, 2024 in Toronto, Canada. The Ziostation REVORAS software is the company's most recent development, offering a scalable, enterprise platform, which enables critical analytical tools such as automatic pulmonary and vein segmentation.

Our software could significantly improve the surgical planning process for complex segmentectomy procedures with potential to revolutionize thoracic surgical planning

"With our advanced Ziostation REVORAS software, we are empowering surgeons with unprecedented capabilities," said Rajeev Taitriya, vice president of marketing and business development for Ziosoft. "This transformative tool enhances surgical planning by providing insights into regions of interest, such as a better understanding of the positional relationships of the bronchi and pulmonary arteries or veins during preoperative planning and intraoperative guidance. For example, our software could significantly improve the surgical planning process for complex segmentectomy procedures with potential to revolutionize thoracic surgical planning."

According to Taitriya, this cutting-edge 3D software identifies candidate segments based on lesion location and margin criteria. The software also provides a detailed stump view of the bronchi and vessels slated for dissection.

It automatically segments thoracic structures with high accuracy including pulmonary arteries and veins from non-contrast DICOM datasets.

"The REVORAS software is Ziosoft's newest simplified platform with an improved GUI, along with several AI algorithms enhancements and novel applications," said Shusuke Chino, co-founder and president, Ziosoft. "Drawing upon more than two decades of medical imaging expertise and deep learning capabilities, our REVORAS platform is the culmination of this extensive experience. We are poised to usher in significant advancements in surgical planning for the operating room of tomorrow."

The Ziosoft platform provides comprehensive applications for thoracic imaging needs. It is customizable with automated workflows to maximize efficiency. As a software-only platform, it is designed to minimize the cost of ownership. The Ziosoft platform also offers its unique PhyZiodynamics 3D/4D solution, as well as recently introduced Zioflex, a monthly subscription program designed to provide a risk-free introduction of Ziosoft's many AV clinical applications.

About Ziosoft.

Founded in 1998 with offices in Japan, the USA and China, Ziosoft is a recognized leader in functional 3D visualization and analysis software to benefit physicians, patients and healthcare specialists. With thousands of systems installed in more than 30 countries worldwide and 900 scientific publications, Ziosoft's true vendor-neutral and multi-modality advanced visualization technology platform is helping patients and clinicians every day, by enabling greater diagnostic confidence, lower dose options, and precision in treatment planning. As a software-only solution, it is simplified to minimize cost of ownership. For further information on Ziosoft, visit http://www.ziosoftinc.com.

Media Contact

Laurie Hallwyler, Ziosoft, 1 6502489081, [email protected], www.ziosoftinc.com

SOURCE Ziosoft


These press releases may also interest you

at 15:25
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

at 11:55
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

at 09:00
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...

at 07:56
RaySearch Laboratories AB (publ) and C-RAD are pleased to announce a collaboration agreement, aiming at jointly developing innovative solutions and products to enhance the quality of radiation therapy. The focus of the collaboration is to...

at 06:00
SecondOpinionExpert, Inc. (SOE), a leading healthcare technology company, announced today that OC Fertility® + OC Biogenix® located in Newport Beach, Orange County, California will join SOE's expert panel to provide second opinions for fertility...

at 05:00
Scientology Network's VOICES FOR HUMANITY, the weekly series presenting heroic change makers from a variety of faiths, cultures and nations, working to uplift their communities, announces a new episode featuring anti-drug activist Robert Galibert....



News published on and distributed by: